Chapter 1: The Quest for Immortality

The quest for eternal life has fascinated humanity for centuries, from mythological tales to modern science. One of the earliest narratives, the Epic of Gilgamesh, tells of a king from the Sumerian city of Uruk seeking immortality. Unfortunately, he did not achieve his goal.

While growing up is a universal desire, aging is often met with reluctance. Aging brings a host of challenges: a decline in immune function, an increased risk of cancer, muscle deterioration, stiffer joints, and memory lapses. Even our microbiome, skin, and body shape undergo changes, leading to a myriad of cellular issues.

Despite these challenges, the age-old quest for understanding and overcoming aging continues. Scientific advancements are gradually revealing the biological intricacies of aging, with researchers exploring molecular manipulations—primarily in laboratory animals at this stage.

However, translating findings from animal studies to human applications is complex and fraught with obstacles. The biological systems are more intricate and context-dependent than initially assumed.

Numerous strategies are being explored to mitigate the effects of aging, including:

• Adopting a healthy lifestyle (though this term can be vague; essentially, eat your fruits and vegetables and stay active)
• Caloric restriction (the specifics of which are still debated in human studies)
• Genetic modifications
• Stem cell research

Additionally, certain drugs show promise in influencing various aging pathways. These potential anti-aging compounds generally fall into three categories: senolytics, inhibitors of the senescence-associated secretory phenotype (SASP), and regulators of nutrient signaling.

Chapter 2: Drug Discovery and the Extracellular Matrix

Finding effective anti-aging drugs is no simple task. It often relies on serendipitous discoveries or the extensive testing of numerous compounds that may interact with aging pathways.

Machine learning technology is emerging as a valuable tool in this area. These systems can sift through vast libraries of compounds to identify those that resemble known anti-aging drugs or those that may influence specific aging pathways. This can narrow down the list of candidates for further testing.

A recent study has focused on the extracellular matrix (ECM) as a potential resource for identifying promising anti-aging drug candidates. The ECM acts as a supportive framework for our cells, composed of various molecules like collagen and glycoproteins. As we age, our ECM also deteriorates.

Interestingly, many compounds being researched for their life-extension properties also affect gene expression within the ECM. Researchers hypothesize that by understanding the age-related changes in the ECM, they can identify compounds that positively influence it, making them prime candidates for further studies.

To begin their investigation, scientists analyzed existing ECM gene expression data to distinguish between young and old 'matrisomes' based on 99 gene expression profiles across 15 tissue types. They subsequently conducted a comprehensive literature review to identify compounds that impact the ECM. From their findings, they identified 185 compounds, with 24 already suggesting potential lifespan extension in laboratory animals.

They then tested some of these compounds in C. elegans, a tiny roundworm frequently used in anti-aging research due to its manageable care requirements and rapid generation cycle.

Among the compounds that exhibited beneficial effects were:

• Vitamin B12: Found in animal products, fermented plant foods, and supplements.
• Chrysin: A flavonoid present in honey, chamomile, and various fruits.
• Dapsone: An antibiotic with notable side effects in humans.
• Metformin: A diabetes medication gaining attention for its anti-aging properties.
• Tretinoin: A medication used for acne and certain types of leukemia.
• Genistein: An isoflavone found in soybeans, lupin, and fava beans.
• Glucosamine, chondroitin sulfate, and hyaluronic acid: Key components of the ECM.

The study concludes that their method showcases the potential of ECM reprogramming as a strategy for identifying compounds—whether licensed drugs, natural substances, or supplements—that may slow or prevent age-related diseases. Understanding how to pharmacologically reprogram our extracellular environments could unveil new therapeutic avenues and significantly aid in disease diagnostics.

While findings from C. elegans are promising, it is crucial to remember that worm biology does not directly translate to human biology. Many compounds that extend lifespan in C. elegans have not succeeded in human trials. Additionally, some compounds, such as dapsone, may cause severe side effects. However, consuming fruits and legumes is generally safe for most individuals, provided there are no allergies or specific health concerns. The latter three compounds mentioned are popular supplements for joint health, although clinical evidence for their effectiveness remains limited.

This video titled "Unlocking Extracellular Matrix, AI / ML, & Longevity Research" features insights into how machine learning is reshaping the search for anti-aging compounds.

In the video "Dr. Collin Ewald | Collagen Protein & Extracellular Matrix During Aging," Dr. Ewald discusses the significance of collagen and the ECM in the aging process.

Support your matrix!